Recruiting Pulmonary Hypertension Studies in Buenos Aires
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
The purpose of this study is to assess the safety and tolerability and to confirm the dose of nemtabrutinib in combination with venetoclax in participants with R/R CLL/SLL. The primary study hypothese...
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
This is a 52-week, randomized, placebo-controlled, double-blind, parallel group, multicenter study of depemokimab in adults with uncontrolled HES receiving standard of care (SoC) therapy. The study w...
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy
A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adults Male Subjects with Cerebral Adrenoleukodystrophy....
A Study to Investigate the Safety, Tolerability, and Efficacy of SAR446268, an Adeno-associated Viral Vector-mediated Gene Therapy in Participants Aged 10 to 50 Years of Age With Non-congenital Myotonic Dystrophy Type 1
This is a Phase 1/Phase 2 open-label single arm, multicenter, and multinational study with SAR446268 for treatment of male and female participants 10 to 50 years old with non-congenital myotonic dystr...
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)
The primary objective of this study is to evaluate the efficacy of ALXN1920 compared with placebo in participants with PMN who are at a high risk for disease progression using 24-hour urine protein cr...
About Pulmonary Hypertension Clinical Trials in Buenos Aires
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
There are currently 5 pulmonary hypertension clinical trials recruiting participants in Buenos Aires, ARGENTINA. These studies are seeking a combined 945 participants. Research is being sponsored by Merck Sharp & Dohme LLC, GlaxoSmithKline, Minoryx Therapeutics, S.L. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Pulmonary Hypertension Clinical Trials in Buenos Aires — FAQ
Are there pulmonary hypertension clinical trials in Buenos Aires?
Yes, there are 5 pulmonary hypertension clinical trials currently recruiting in Buenos Aires, ARGENTINA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Buenos Aires?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Buenos Aires research site will contact you about next steps.
Are clinical trials in Buenos Aires free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Buenos Aires studies also compensate for your time and travel.
What pulmonary hypertension treatments are being tested?
The 5 active trials in Buenos Aires are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary hypertension.
Data updated March 2, 2026 from ClinicalTrials.gov